Abstract:Atherosclerosis is one of the leading causes of cardiovascular diseases and is triggered by endothelial damage, local lipid cumulation, and inflammation. Despite the conventional medication treatment, nanosized drug carriers have become promising candidates for efficient drug delivery with lower side effects. However, the development of problems in nanocarriers such as drug leakage, accumulating efficiency, and accurate drug release, as well as the specific recognition of atherosclerotic plaques, still needs to be checked. In this study, a lipid-specific fluorophore (LFP) has been designed, which is further packaged with a reactive oxygen species (ROS)-responsive prednisolone (Pred) prodrug copolymer [PMPC-P(MEMA-co-PDMA)] to self-assemble into micelles. can be further coated with red blood cell (RBC) membrane to obtain surface-biomimetic nanoparticles (RBC/), demonstrating prolonged circulation, minimal drug leakage, and better accumulation at the plaques. With ROS responsiveness, RBC/ can be interrupted at inflammatory atherosclerotic tissue with overexpressed ROS, followed by the dissociation of Pred from the polymer backbone and the release of LFP to combine with the rich lipid in the plaques. An accurate anti-inflammation and lipid-specific fluorescent imaging of atherosclerotic lesions was performed and further proven on ApoE–/– mice; this holds prospective potential for atherosclerosis theranostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c08552?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c08552</a>.Materials purchase, synthesis of LFP and polymer, ROS responsiveness, in vitro cytotoxicity, anti-inflammation effect, animal model construction, acute toxicity evaluation, pharmacokinetics study and statistical analysis, 1H NMR spectra, high-resolution mass spectrometry, cmc determination, size stability, in vitro cytotoxicity, distribution in organs, pharmacokinetics, and in vivo acute toxicity (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c08552/suppl_file/am1c08552_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A Dual-Targeting Therapeutic Nanobubble for Imaging-Guided Atherosclerosis Treatment

Aiming at Early-Stage Vulnerable Plaques: A Nanoplatform with Dual-Mode Imaging and Lipid-Inflammation Integrated Regulation for Atherosclerotic Theranostics

Molecular Imaging of Atherosclerotic Plaque with Lipid Nanobubbles As Targeted Ultrasound Contrast Agents

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis

Ultrasound-assisted Biomimetic Nanobubbles for Targeted Treatment of Atherosclerosis

Ultrasound Molecular Imaging of Atherosclerosis for Early Diagnosis and Therapeutic Evaluation through Leucocyte-like Multiple Targeted Microbubbles.

Dual-Function Nanoscale Coordination Polymer Nanoparticles for Targeted Diagnosis and Therapeutic Delivery in Atherosclerosis

Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation

A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis

Design of simvastatin-loaded polymeric microbubbles as targeted ultrasound contrast agents for vascular imaging and drug delivery in the identification of atherosclerotic plaque

Controllable Thrombolysis Using a Nanobubble-Imaging-Guided Rtpa Targeted Delivery Strategy

Targeted Delivery of Nanoparticles to Blood Vessels for the Treatment of Atherosclerosis

Dual-responsive Targeted Atherosclerosis Therapy through a Multi-effective Nanoplatform with Anti-inflammatory, Lipid-regulating and Autophagy

Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques

Detection and Treatment of Atherosclerosis Using Nanoparticles.

An Ultrasound-Responsive Theranostic Cyclodextrin-Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis

Platelet-derived Nanomotor Coated Balloon for Atherosclerosis Combination Therapy.

Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics

Targeting Theranostics of Atherosclerosis by Dual‐Responsive Nanoplatform via Photoacoustic Imaging and Three‐In‐One Integrated Lipid Management

Endothelium-targeted NF-κB siRNA nanogel for magnetic resonance imaging and visualized-anti-inflammation treatment of atherosclerosis

Nanomedicine for Atherosclerosis: Molecular Imaging and Treatment.